Vitamin K
Showing 26 - 50 of 6,412
Real Life of New Oral Anticoagulants and Vitamin K Antagonists
Completed
- Atrial Fibrillation
- Direct oral antocoagulant: dabigatran, rivaroxaban, apixaban
- Vitamin K antagonist: warfarin, fluindione, acenocoumarol
-
Paris, FranceAssistance Publique Hôpitaux de Paris
Mar 28, 2022
Coronary Artery Calcification, Arterial Stiffness Trial in Copenhagen (Menaquinone-7 (MK-7) tablet (333 µg), Placebo tablet)
Recruiting
- Coronary Artery Calcification
- Arterial Stiffness
- Menaquinone-7 (MK-7) tablet (333 µg)
- Placebo tablet
-
Copenhagen, Glostrup, DenmarkCenter for Clinical Research and Prevention
Jun 21, 2022
Covid19 Trial in Ottawa (drug, dietary supplement, other)
Suspended
- Covid19
- Vitamin D3 50,000 IU
- +4 more
-
Ottawa, Ontario, CanadaThe Centre for Health Innovation
Aug 8, 2022
Ischemic Stroke, Anticoagulant Adverse Reaction Trial in Taipei (Dabigatran, rivaroxaban, apixaban, edoxaban)
Recruiting
- Ischemic Stroke
- Anticoagulant Adverse Reaction
- Dabigatran, rivaroxaban, apixaban, edoxaban
-
Taipei, TaiwanNational Taiwan University Hospital
Nov 22, 2023
Non-vitamin K Antagonist Oral Anticoagulant Concentration and
Recruiting
- Atrial Fibrillation
- Data collection
-
Taipei, Please Select, Taiwan
- +1 more
Apr 17, 2022
Glioblastoma, Glioblastoma Multiforme Trial in United States (drug, other, radiation)
Recruiting
- Glioblastoma
- Glioblastoma Multiforme
- BPM31510
- +3 more
-
Los Angeles, California
- +3 more
May 31, 2022
Intracerebral Hemorrhage Trial in Basel (Tranexamic acid, Saline 0.9%)
Completed
- Intracerebral Hemorrhage
- Tranexamic acid
- Saline 0.9%
-
Basel, SwitzerlandStroke Center, University Hospital Basel
Mar 22, 2022
Maintenance Dose, Osteocalcin, Vitamin K Deficiency Trial in Skjetten (Jarlsberg Cheese)
Completed
- Maintenance Dose
- +2 more
- Jarlsberg Cheese
-
Skjetten, Akershus, NorwaySkjetten Legesenter
Jun 27, 2022
Vascular Calcification Trial in Assiut (oral vitamin k1 (phylloquinone))
Completed
- Vascular Calcification
- oral vitamin k1 (phylloquinone)
-
Assiut, EgyptAssiut University Hospital
Sep 28, 2021
CTEPH Trial in Fukuoka (Edoxaban, Warfarin Potassium, Warfarin Potassium )
Active, not recruiting
- CTEPH
- Edoxaban
- +3 more
-
Fukuoka, JapanKyushu University Hospital
Aug 30, 2022
Cystic Fibrosis Trial in Montréal (Vitamin K supplementation, dose #1, Vitamin K supplementation, dose #2)
Withdrawn
- Cystic Fibrosis
- Vitamin K supplementation, dose #1
- Vitamin K supplementation, dose #2
-
Montréal, Quebec, Canada
- +1 more
Aug 16, 2021
Muscle Atrophy, Cachexia Trial in Kaunas (Vitamin K2)
Not yet recruiting
- Muscle Atrophy
- Cachexia
- Vitamin K2
-
Kaunas, Lithuania
- +1 more
Dec 2, 2021
Coronary Artery Disease Trial in Odense (Vitamin K2 (Menaquinone-7))
Not yet recruiting
- Coronary Artery Disease
- Vitamin K2 (Menaquinone-7)
-
Odense, Odense C, DenmarkDepartment of Cardiology, Odense University Hospital
Aug 11, 2022
Oxidative Stress, Inflammation Trial in Corciano (Ozonized vegetable oil with vitamines)
Active, not recruiting
- Oxidative Stress
- Inflammation
- Ozonized vegetable oil with vitamines
-
Corciano, Perugia, ItalyCrabion srl
Oct 20, 2022
Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute
Recruiting
- Therapeutic Drug Monitoring
- Blood sampling to test drug level
-
Taipei, TaiwanNational Taiwan University Hospital
Mar 8, 2022
Nonvalvular Atrial Fibrillation Trial in Angers (Rivaroxaban 20 MG, Warfarin)
Recruiting
- Nonvalvular Atrial Fibrillation
- Rivaroxaban 20 MG
- Warfarin
-
Angers, FranceAngers University Hospital
Jul 25, 2022
End Stage Renal Disease on Dialysis Trial in Cairo (Vitamin K1, Vitamin k2, )
Completed
- End Stage Renal Disease on Dialysis
- Vitamin K1
- +2 more
-
Cairo, EgyptAinshams University
Jul 19, 2021
Burns Trial in Augusta (Vitamin K)
Recruiting
- Burns
- Vitamin K
-
Augusta, GeorgiaJoseph M. Still Burn Center at Doctors Hospital
Aug 24, 2021
Evaluating the Vitamin K2 Status of Calcium-based Stone Formers
Not yet recruiting
- Kidney Calculi
- +7 more
- (no location specified)
Oct 5, 2021
NOACs Use in AF or VTE (SUNSHINE Registry)
Recruiting
- Atrial Fibrillation
- +2 more
- Patients with Atrial Fibrillation (AF) or venous thromboembolism (VTE)
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jun 6, 2022
Atrial Fibrillation Trial (Non-vitamin K oral anticoagulants (NOACs), Warfarin)
Not yet recruiting
- Atrial Fibrillation
- Non-vitamin K oral anticoagulants (NOACs)
- Warfarin
- (no location specified)
Aug 6, 2021
Aortic Valve Stenosis, Multidetector Computed Tomography, Vitamin K 2 Trial in Odense (Menaquinone-7 720 µg/day including the
Completed
- Aortic Valve Stenosis
- +3 more
- Menaquinone-7 720 µg/day including the recommended daily dose of vitamin D (25 µg/day).
- Placebo
-
Odense, Odense C, DenmarkDepartment of Cardiology, Odense University Hospital
Sep 28, 2022
Diabetes Type 2 With Periodontal Disease Trial in Kirikkale (Vitamin D3K2, Saline Solution)
Completed
- Diabetes Mellitus Type 2 With Periodontal Disease
- Vitamin D3K2
- Saline Solution
-
Kırıkkale, TurkeyKirikkale University
Oct 5, 2023
Intra-cardiac Thrombus, STEMI, Heart Failure Trial in France, Réunion (Vitamin K antagonist, Direct oral anticoagulant)
Not yet recruiting
- Intra-cardiac Thrombus
- +2 more
- Vitamin K antagonist
- Direct oral anticoagulant
-
Angers, France
- +33 more
Apr 11, 2023
Gather Information About Rivaroxaban in Sweden With Cancer Who
Active, not recruiting
- Treatment of Venous Thromboembolism in Cancer Patients
- Rivaroxaban (Xarelto, BAY59-7939)
- +3 more
-
Multiple Locations, Many Locations, SwedenSwedish registries
Aug 18, 2022